This #CME activity focuses in on the structure and pathophysiology of Lp(a). Participate and claim your credits today >> ow.ly/yLlv50OrWzH

Complete our new activity "Cardiovascular Disease: Saving the Hearts of Women Through Prevention" to earn 1.75 #CME credits and learn more about CVD risk factors, diagnostic tools, and guidelines related to screening women for CV risk >> ow.ly/2oxs50Q47pQ

In this interactive #CME activity, expert faculty addresses CVD risk factors, diagnostic tools, and guidelines related to screening women for CV risk. Participate today and claim your #FreeCME: ow.ly/2oxs50Q47pQ

This #CME activity examines challenges in the measurement of lipoprotein a [Lp(a)], as well as clinical evidence for current and emerging therapies to manage women with elevated Lp(a). Participate today and claim your #FreeCME >> ow.ly/2oxs50Q47pQ

This #CME activity reviews the role of Lp(a) as a risk factor in atherosclerotic cardiovascular disease. Participate today and claim your #FreeCME >> ow.ly/yLlv50OrWzH

Calling all #cardiologists: Which of these answers is TRUE? For the correct answer and to complete this entire activity focused on preventing cardiovascular disease in women, click this link Participate today and claim your #FreeCME >>ow.ly/2oxs50Q47pQ

Examine evidence-based strategies to identify patients who are at risk for cardiovascular events and may benefit from reduction of Lp(a) with this #CME activity >> ow.ly/yLlv50OrWzH

Complete this #CME activity "Cardiovascular Disease: Saving the Hearts of Women Through Prevention" featuring the unique, educational gaming platform, Wheel of Knowledge Challenge! >> ow.ly/2oxs50Q47pQ

Test your knowledge of Lp(a) with this #CME activity >> ow.ly/yLlv50OrWzH Alan Brown MD MHA FACC FNLA Marlys Koschinsky Dr. James Underberg @jpenamd

This #CME activity focuses on CVD risk factors, diagnostic tools, and guidelines related to screening women for CV risk. Participate today and claim your #FreeCME >> ow.ly/2oxs50Q47pQ

Calling all #cardiologists: Which of the following regarding the epidemiology of ASCVD in women is true? For this answer and to learn more about preventing cardiovascular disease in women, click this link: ow.ly/2oxs50Q47pQ

Explore the critical role of LDL-C in #ASCVD, and learn about innovative treatments for hyperlipidemia in our CE program. >> ow.ly/3Ioi50SXXnF Alan Brown MD MHA FACC FNLA Christie Ballantyne Dr. James Underberg Dr. Payal Kohli, MD

Calling all #cardiologists: Which of the following regarding the epidemiology of ASCVD in women is true? For this answer and to learn more about preventing cardiovascular disease in women, click this link: ow.ly/2oxs50Q47pQ

Understand Lp(a) as a standalone risk factor in #ASCVD and the need for improved screening and management strategies. Enhance your clinical skills with this activity >> ow.ly/3Ioi50SXXnF Alan Brown MD MHA FACC FNLA Christie Ballantyne Dr. James Underberg Dr. Payal Kohli, MD

"Cardiovascular Disease: Saving the Hearts of Women Through Prevention" expires THIS MONTH! Make sure to participate and claim your #FreeCME before it's too late! >> ow.ly/2oxs50Q47pQ

In this #CME activity,Alan Brown MD MHA FACC FNLA Christie Ballantyne Dr. James Underberg Dr. Payal Kohli, MD focus on innovative treatments and interprofessional care. Participate & claim your credits today >> ow.ly/3Ioi50SXXnF

Test your knowledge on LDL-C, Lp(a), and patient care strategies with this #CME activity >> ow.ly/3Ioi50SXXnF Alan Brown MD MHA FACC FNLA Christie Ballantyne Dr. James Underberg Dr. Payal Kohli, MD

Dive into lipid management with our "Clinical Counterpoints" format, using case studies to explore LDL-C, Lp(a), and patient care strategies. >> ow.ly/3Ioi50SXXnF Alan Brown MD MHA FACC FNLA Christie Ballantyne Dr. James Underberg Dr. Payal Kohli, MD

Learn to identify patients with elevated Lp(a) at risk for CV events and apply the latest guidelines for managing elevated LDL-C. Participate today and claim your #FreeCME >> ow.ly/3Ioi50SXXnF Alan Brown MD MHA FACC FNLA Christie Ballantyne Dr. James Underberg Dr. Payal Kohli, MD

Explore clinical evidence and evaluate the safety and efficacy of current and emerging therapies for Lp(a) and LDL-C management. >> ow.ly/3Ioi50SXXnF Alan Brown MD MHA FACC FNLA Christie Ballantyne Dr. James Underberg Dr. Payal Kohli, MD